Forschungsprojekte
Ergebnisse pro Seite:
50
2019 - 2020
Monozentrische Erfahrungen mit stereotaktischer Bestrahlung (SBRT) beim fortgeschrittenen hepatozellulären Karzinom.- Juniorprof. Dr. Jens UweMarquardt,
- Dr. CarolinCzauderna
2018 - 2023
Characterization of immunopathogenesis and inflammation in acute and chronic liver diseases.- PD Dr. MartinSprinzl
2018 - 2020
Mitochondria re-distribution of the BCL-2 protein BAX in human hepatocellular carcinoma induces high apoptosis resistance and sensitivity to DNA repair inhibition- Juniorprof. Dr. Jens UweMarquardt,
- Dr. CarolinCzauderna
2018 - 2021
“Characterization and modulation of innate myeloid cells in hepatocellular carcinoma”.- Univ.-Prof. Dr. Dr. DetlefSchuppan,
- PD Dr. MartinSprinzl
2018 - 2021
SFB1292 Targeting convergent mechanisms of inefficient immunity in tumors and chronic infections - TP 15 Defining the role of hepatocellular carcinoma-related epigenetic alterations driving immune evasion- Prof. Dr. SusanneStrand,
- Univ.-Prof. Dr. JensMarquardt
2017 - 2019
Selektive Applikation von Bax-Fusionsproteinen zur Apopotose-Initiation in gastrointestinalen Tumorzellen- Juniorprof. Dr. JensMarquardt
2017 - 2020
Multinational, multicentric, randomized, controlled clinical phase III-trial to evaluate the efficacy of MK-3475 (pembrolizumab) vs. standard chemotherapy in patients with stage IV colorectal carcinoma with high microsatellite instability or deficient mismatch-repairing system- Prof. Dr. MarkusMöhler
2017 - 2019
Untersuchung der Ergebnisse nach TIPS-Anlage wegen therapierefraktärem Aszites und Ösophagusvarizenblutungen. Klinische Studie, monozentrisch, retrospektiv- Prof. Dr. Michael B.Pitton,
- PD Dr. TimZimmermann,
- Dr. MariaHoppe-Lotichius
2017 - 2020
"Validierung neuer Biomarker der Leberschädigung und Hepatokarzinogenese bei Patienten- Dr. YvonneHuber
2017 - 2021
SEAL - Structured Early Assessment of Asymptomatic Liver Fibrosis and Cirrhosis- Univ.-Prof. Dr. Peter RobertGalle
2017 - 2020
Liver function decline prediction in patients with hepatocellular carcinoma undergoing TACE using LiMAx (TACE-LiMAx)- PD Dr. Marcus-AlexanderWörns
2017 - 2020
Neue anti-fibrotische Makrolactone zur Behandlung progredienter chronischer Nierenerkrankungen.- PD Dr. JuliaWeinmann-Menke
2017 - 2019
Inneruniversitäre Forschung Stufe I der Universitätsmedizin Mainz, 2017-2018 SLEEP-Studie (Systemic Lupus Erythematodes Exercise Program)- PD Dr. JuliaWeinmann-Menke
2017 - 2020
S-AVANT – Follow-up to the AVANT study up to 8 and 10 years (median follow up) in patients with colon carcinoma- Prof. Dr. MarkusMöhler
2016 - 2020
A Phase III open-label, multicenter trial of maintenance therapy with Avelumab* (MSB0010718C) versus continuation of first-line chemotherapy in subjects with unresectable, locally advanced or metastatic adenocarcinoma of the stomach or of the gastro-esophageal junction- Prof. Dr. MarkusMöhler
2016 - 2019
Analysis of ACPAs in patients with very early rheumatoid arthritis (VERA) and patients with yet unclassified arthritis (UA) in the Rheumatology network ADAPTHERA- Univ.-Prof. Dr. AndreasSchwarting
2016 - 2018
Guideline Programme-Oncology: Update of the guideline gastric carcinoma (S3)- Prof. Dr. MarkusMöhler
2016 - 2018
CFZ 533: An open label study to evaluate the safety and efficacy of 12 week treatment with CFZ533 in patients with Graves' disease- Prof. Dr. Georg J.Kahaly